The Beauty Health pany(US:SKIN) Yahoo Finance·2025-11-06 23:00Core Insights - The Beauty Health Company (SKIN) reported a revenue of $70.7 million for the quarter ended September 2025, reflecting a 10.3% decline year-over-year [1] - The company's EPS was -$0.09, an improvement from -$0.15 in the same quarter last year, but below the consensus estimate of -$0.08, resulting in a surprise of -12.5% [1] - The revenue exceeded the Zacks Consensus Estimate of $68.75 million by 2.84% [1] Revenue Breakdown - Geographic Revenue in the Americas was $48.3 million, surpassing the estimated $46.45 million, but down 6.9% from the previous year [4] - EMEA revenue stood at $16.1 million, slightly above the estimated $15.94 million, with no year-over-year change [4] - Asia Pacific revenue was $6.3 million, exceeding the estimate of $6 million, but down significantly by 41.7% compared to the year-ago quarter [4] Sales Performance - Delivery Systems Net Sales reached $20.8 million, exceeding the estimate of $17.03 million, but down 24.6% year-over-year [4] - Consumables Net Sales were reported at $49.8 million, slightly below the estimated $51.36 million, reflecting a 2.7% decline from the previous year [4] Stock Performance - Over the past month, shares of Beauty Health have declined by 13.5%, contrasting with a 1.3% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]